13.02.15 Plastics notes
Hilton's Law
Nerve that innervates a joint also tends to innervate the muscles that move the joint and the skin that covers the distal attachments of those muscles
For example, musculocutaneous nerve:
Supplies biceps brachii + brachialis
Also supplies the elbow joint with pain and proprioception fibres
Also supplies the forearm skin around the elbow (close to the insertion of each of those muscles)
Melanoma history
Age
Occupation
Outside work?
Country of birth
Past sun exposure
Sunburnt?
Skin type / Response to sun
History of lesion
When noticed
When GP consulted
Referrals
Any other moles
PMH
FHx of skin or other cancer
Fungating man
Differentials
SCC / MM
BCC never look like that
Smell
Farty smell = Anaerobes
=> Metroniazole
Melanoma staging
Breslow thickness => 5-year survival
<1 mm => 95-100%
1 - 2 mm => 80-96%
2 - 4 mm => 60-75%
>4 mm => 50%
Ulceration is bad
Nodes
CT for haematogenous spread
Skin types (Fitzpatrick Scale)
Type I
Light, pale white
Always burns, never tans
Type II
White; fair.
Usually burns, tans with difficulty
Type III
Medium, white to light brown.
Sometimes mild burn, gradually tans to a light brown
Type IV
Olive, moderate brown
Rarely burns, tans with ease to a moderate brown
Type V
Brown, dark brown
Very rarely burns, tans very easily
Type VI
Black, very dark brown to black
Never burns, tans very easily, deeply pigmented
Seborrheic keratosis
Noncancerous benign skin growth
Originates in keratinocytes
Seen more often as people age
Appearance:
"Pasted on"
Various colors, from light tan to black
Round or oval
Feel flat or slightly elevated (like the scab from a healing wound)
Range in size from very small to more than 2.5 centimetres across
Resemble
Warts
Melanoma
Gastrointestinal stromal tumor (GIST)
Definition
Common GI mesenchymal tumor
1-3% of all gastrointestinal malignancies
Defined as tumors whose behavior is driven by mutations in the Kit or PDGFRA genes
Sarcomas (connective tissue)
cf Most other GI tumours
70-80% are benign
Signs and symptoms
Vague abdo pain
Trouble swallowing
GI bleed
Mets
Intestinal obstruction is rare, due to the tumor's outward pattern of growth
Location
70% stomach
20% small intestine
10% oesophagus
Therapy
All GIST tumors should be considered to have malignant potential and no GIST tumor can be correctly classified as "benign."
Surgery is mainstay
c-kit tyrosine kinase inhibitor imatinib => 40-70% response rate in metastatic/inoperable cases
Initially marketed for CML
Also useful in dermatofibrosarcoma protuberans (DFSP)
Notes
Charcot joint
Eccrine porocarcinoma